NETSANET TEFERA: Open Payments
NPI 1154973147 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,230 in 48 payments from 18 companies in 2025. Trend: 2023 $1,697 · 2024 $1,615 · 2025 $1,230
Food & beverage: $1,230
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $212 |
| AstraZeneca Pharmaceuticals LP | 3 | $186 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $76 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Medtronic, Inc. | 2 | $72 |
| Novo Nordisk Inc | 4 | $72 |
| Astellas Pharma US Inc | 3 | $70 |
| Dexcom, Inc. | 3 | $66 |
| Sumitomo Pharma America, Inc. | 3 | $60 |
| Abbott Laboratories | 3 | $59 |
Products named: EVENITY, BREZTRI, Veozah, Dexcom G6 Transmitter, AIRSUPRA, GEMTESA, FREESTYLE LIBRE 3, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
